AMP 2019 PGx Workshop: The Prevalence and Impact of CYP2D6 Hybrid Alleles

This expert workshop presentation discusses why many PGx detection methods are not equipped to detect prevalent CYP2D6 hybrid alleles and how the subsequent sample mischaracterization impacts PGx results. We also discuss solutions to improve accuracy.

Recorded on Wednesday, November 6, 2019 at the AMP 2019 Annual Meeting & Expo, held at the Baltimore Convention Center in Baltimore, MD.

Presenters:

Houda Hachad, Pharm.D, Chief Scientific Officer, Translational Software

Carissa Wachtler, MB(ASCP)CM, Chief Technology Officer/VP Research and Development, AccessDx

Darryl Irwin, PhD, Senior Director, Scientific Affairs, Agena Bioscience

pgx,pharmacogenetics,pharmacogenomics,PGx testing,hybrid alleles,amp 2019,agena,agena bioscience,massarray,workshop,PGx workshop,